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Colorectal surgery: Current practice & future developmentsqThe ﬁrst report of laparoscopic colorectal resections in 19911 rep-
resented a major advance in the progress and practice of colorectal
surgery. Since then, the rate of new evolutions and innovations
seems to have acquired a rapid momentum for change. A critical
overview of the published literature in colorectal surgery over the
last year conﬁrms that this drive for progress and change in practice
is likely to get stronger and the debate on various unresolved issues
in the contemporary practice of colorectal surgery is far from over.
1. Laparoscopic colorectal surgery (LCS)
1.1. Expanding indications for LCS
It has been established that LCS is safe and effective for benign &
malignant disease, and results improved short-term outcomes
compared to open colorectal surgery.2 Increasing number of recent
studies have reported that the laparoscopic approach is safe even in
obese patients,3 complicated diverticular disease,4 large bowel
obstruction5 and T4 tumours.6 These were previously contraindica-
tions for the laparoscopic approach.
1.2. Enhanced recovery after surgery (ERAS) in LCS
It has been debated previously whether the implementation of
ERAS is of value in the context of LCS.7 This has been addressed
by a recent randomised controlled trial (RCT) which concluded
that the optimal perioperative management for patients requiring
segmental colectomy is LCS embedded in ERAS program.8 The
cost implications in providing ERAS is justiﬁed as a recent
controlled cost analysis indicates that overall healthcare provider
costs are signiﬁcantly reduced in ERAS settings because of a reduc-
tion in bed days and complications.9
1.3. Cost implications in LCS
The introduction of LCS was plagued with concerns about its
cost implications in already ﬁnancially strained healthcare systems.
These concerns have been unfounded.10 Also, when the cost of LCS
is analysed over time, it is projected that the results of future
economic evaluations will unequivocally show that LCS is cheaper
than open surgery when practised in Western healthcare systems
where post-operative care cost is high. The reduction in hospital
stay following LCS reduces the overall cost of the procedure.
However, in Asian healthcare systems, operative costs overshadow
the cost savings gained by reduced hospital stay. Therefore, LCS willq This paper was not peer-reviewed.
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doi:10.1016/j.ijsu.2012.02.016remain more expensive in developing countries compared with
open surgery until manufacturers can reduce intra-operative
equipment cost. This might put patients in some countries at an
underprivileged position regarding access to LCS.11
1.4. Single incision laparoscopic surgery (SILS) in colorectal surgery
There are increasing number of reports on the use of SILS to
perform segmental colectomies12,13 and rectal resections14,15 The
exact role of SILS would become clearer in the future as there are
a number of studies claiming that it does offer more than cosme-
sis.16,17 SILC is feasible when performed on selected patients by
surgeons with extensive LCS experience with short-term outcomes
similar to conventional laparoscopic colorectal surgery, except for
a reduction in peak pain score on the ﬁrst post-operative day.
RCT should be performed before incorporation of this technology
into routine surgical care.18
2. Rectal cancer
2.1. Surgical approaches & techniques in rectal cancer
It took over a decade of debate and controversy to establish that
laparoscopic colonic resections for cancer, when compared with
open surgery, is associated with better short-term outcomes while
maintaining at least equivalent long-term outcomes.19 However,
the debate around laparoscopic rectal surgery is far from over.
Even though there are several studies on the outcomes of laparo-
scopic rectal surgery, there is limited level 1 evidence in surgical
literature.20 Safety and beneﬁts associated with laparoscopic colon
cancer surgery have been demonstrated in many RCTs. However
the same beneﬁts have not yet been clearly conﬁrmed for laparo-
scopic rectal cancer surgery.19 The debate around laparoscopic
rectal surgery has become even more complex with the slow, but
steady, increase in the use of robotics in rectal surgery.
2.2. Robotic rectal surgery
Robotic systems can address many of the inherent limitations of
conventional LCS which are particularly relevant when performing
laparoscopic dissection in the conﬁnes of the pelvis. These include
the fulcrum effect, poor depth perception, limited range of motion
as wells as instrument tremor.21 The use of robotic systems in rectal
cancer surgery has the potential to overcome these limitations.
Ultralow rectal dissection could be more easily performed by using
precise movements of robotic arms.22 However, the debate here is
whether the time and cost involved in using the robot will bed. All rights reserved.
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scopic Resection for Rectal cancer (ROLARR) is designed to address
this question.23 Currently available literature suggests that robotic
rectal dissection is particularly useful in male patients, in mid and
low rectal lesions, and in patients who had preoperative neoadju-
vant chemoradiation.22,24
2.3. Distal resection margin (DRM) in rectal cancer
There is a fresh debate on the optimal length of DRM in rectal
cancer surgery.25 The standard recommendation that a 2 cm DRM
for upper & middle, and a 1 cm DRM for distal rectal cancers are
needed to decrease the risk of local recurrence26 has been chal-
lenged as in patients who underwent preoperative radiation for
advanced rectal cancer a DRM of less than 5 mm did not compro-
mise oncological safety.27,28
However, in patients who did not undergo preoperative neoadju-
vant therapy the prevalence of distal spread increased with TNM
stage as multivariable analysis showed that nodal involvement and
distant metastasis were independent risk factors for distal spread.
Also, distant metastasis was the only independent risk factor for
long distal spread. These results suggest that TNM stage should be
taken into account when determining the optimal distal margin in
patients with rectal cancer29 and it has been suggested that a further
increase of 1–2 cm beyond the recommended DRM may contribute
to better local control in patients with distant metastasis.25
2.4. Extended resection for low rectal cancer
It is now accepted that standard abdominoperineal excision
(APE) gives inferior results compared to anterior resection in rectal
cancer surgery due to increased risk of rectal or tumour perforation
and circumferential resection margin (CRM) involvement30 which
lead to increasing interest in extended, cylindrical or extralevator
APE (ELAPE). ELAPE does improve the rates of inadvertent bowel
perforation and CRM involvement. However, the beneﬁt of ELAPE
versus standard APE for survival cannot be determined from the
currently available literature.31,32 There are some reports of laparo-
scopic and robotic assisted ELAPE which might enhance the
surgical technique even further.33,34
3. Lymph nodes (LN) in colorectal cancer
There is renewed critical interest in the current guidelines
related to lymph nodes retrieval in colorectal cancer specimens
with some recent analysis have rejected the concept that a ﬁxed
minimum value of 12 lymph node as multiple tumour and surgical
factors can affect LN yields. Technical factors of LN yield were
recently reported to include the extent of mesenteric resection
and the use of in vivo endoluminal dye placed at any interval prior
to resection. Tumour factors such as tumour location and size were
also found to be independently associated with LN yield. The
importance of tumour size rather than tumour stage as a predictor
of LN yields has only been recently demonstrated.35
There is growing emphasis that positive lymph node ratio
(pLNR) is a superior prognostic scoring system than standard
TNM classiﬁcation.36 Some authors suggest that adding the LNR
concept to the AJCC cancer staging system will improve its
accuracy.37
The concept of LNR might be particularly useful in patients who
undergo neoadjuvant chemoradiation before rectal cancer surgery
as these patients frequently have fewer than 12 lymph nodes har-
vested despite maintaining vigorous surgical standards.38
It should be noted that LNR independently estimates survival in
Stage III colon cancer irrespective of number of nodes examined.However, statistically signiﬁcant differences in each LNR stratum
between those with resection of fewer than 12 or 12 nodes or
more would indicate that a 12-node minimum may still be neces-
sary for accurate staging.39
Also, it was found that LN distribution is an independent
predictor of survival for colorectal cancer patients, but it does not
predict local recurrence.40 Apical node metastasis appears to be
a strong independent, negative prognostic factor of poor survival
in Dukes C.41 However, sentinel lymph node mapping in colon
carcinoma cannot accurately predict nodal status.42
4. Mechanical bowel preparation (MBP) in elective colorectal
surgery
The routine use of MBP has been gradually decreasing as many
studies consistently found no convincing evidence for its short-
term beneﬁts,43 with some studies reported that the incidence of
anastomotic leakagewas signiﬁcantly higher amongpatients treated
with MBP and that there was a trend towards poorer short-term
outcomes. Also, neither post-operative complications nor long-
term survival are improved byMBP before colonic cancer surgery.44
5. Management of acute diverticulitis (AD)
Several publications have challenged the previous practice
parameters of the main associations of colorectal surgery that elec-
tive surgery should be offered after two episodes of uncomplicated
AD or after one episode in young patients.45–47 The current state-
ment is that there is good clinical and experimental evidence
against the previous recommendations for elective resection.
Currently, it is believed that the expectant management is associ-
ated with lower rates of death and colostomy and incurs lower
costs. Also, there is no clear evidence that younger patients pre-
senting with AD exhibit a more aggressive form of the disease.47
The vast majority of patients who need emergency surgery do
not have a prior history of diverticular disease and therefore it is
questionable that elective surgery would decrease morbidity &
mortality.48 The heterogeneity of patients with colonic diverticular
disease means that both elective and urgent treatment should be
tailored on an individual basis.47
There has been paradigm shift in the management of acute
complicated diverticulitis, which is to convert an emergency
surgical situation, with the use of aggressive supportive medical
care, into an elective surgical situation. The diagnostic accuracy of
modern CT scans allows accurate diagnosis and the use of CTguided
drainage when needed making surgical intervention required only
for those in whom aggressive non-operative management has
failed or who present with haemodynamic instability or general-
ised peritonitis. Dharmarajan et al.49 developed a CT grading
system for perforated diverticulitis and reported that, even in
patients with free air remote from the site of perforation, non-
operative management has 90% success rate in avoiding the need
for urgent operation and stoma creation. Adoption of CT grading
system in complicated AD could help to guide its management
and objective comparison of the outcome of the different treatment
modalities in future studies
The surgical alternatives in emergency surgery for AD are still
a matter of debate as it has been shown that the choice of surgical
technique seems to have only a partial inﬂuence on the overall
outcome.50 Several studies have conﬁrmed an increased survival
in patients treated with primary resection and anastomosis
compared with those treated with three-stage surgery.47 Even
though Hartmann’s operation allows avoidance of anastomotic
leakage, reversal is associated with substantial morbidity and
mortality, with an anastomotic leakage of up to 25%.51 At present
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mosis in selected patients52 even in the presence of localised or
diffuse peritonitis.51 However, most authors still agree that primary
anastomosis is contraindicated in faecal peritonitis, septic shock,
haemodynamic instability, chronic steroid therapy and poor condi-
tion of the patient and possibly obesity.47
A recent reviewarticle on the role of laparoscopic lavage & inser-
tion of drains in AD concluded that this approach appears to be
a potentially effective alternative to a Hartmann’s procedure.
However, RCTs are needed to better evaluate its role.53
So there is a clear recent decline of using Hartmann’s procedure
as the standard procedure in surgery for complicated AD. However,
further studies are needed to assess the indications and outcomes
of the other newly adopted treatment strategies.
The current practice that after an initial episode of acute diver-
ticulitis the colon should be evaluated to exclude neoplasia54 has
been challenged as this practice dates back to the era before the
widespread use of CT to diagnose acute diverticulitis. The yield of
advanced colonic neoplasia in patients with acute uncomplicated
diverticulitis diagnosed by CT was equivalent to, or less than that
detected by screening asymptomatic average-risk individuals.
Therefore, it could be argued that in the absence of other indica-
tions, subsequent evaluation of the colon may not be required to
conﬁrm the diagnosis.55 However, a large-scale conﬁrmatory study
should be undertaken before practice parameters are changed.
Evidence for medical therapy of diverticular disease in reducing
symptoms and preventing AD is rather limited. Some studies
reported signiﬁcant improvement in symptoms and greater preva-
lence of symptom-free patients at 1 year with ﬁbre plus Rifaximin
(non-absorbable antibiotic) in comparison with ﬁbre alone, but
with a number needed to treat of 57, to prevent an attack of acute
diverticulitis.56
6. Minimally invasive procedures for haemorrhoids
The use of Stapled Hemorrhoidopexy (SH) for the treatment of
symptomatic haemorrhoids has become increasingly popular in
the past decade. However, the results of meta-analyses show
important disadvantages such as rectal bleeding, persistent anal
pain, anal incontinence, and a recurrence rate up to 50% in grade
IV haemorrhoids.57,58 Repeat SH could be offered for recurrent
disease but this was found to be associated with higher pain scores,
more analgesic requirements, and longer recovery compared to the
ﬁrst procedure.59
SHmay result in short- and long-term complications, such as anal
stenosis, incontinence, faecal urgency, as well as persistent and
intense pain.60 A recent publication highlighted some rare, but
serious unconventional complications of SH including stable haema-
toma, active haematoma, rectovaginal ﬁstula, pelvic sepsis, perineal
necrosis, deﬁcient suture line, prolonged or chronic anal pain, impor-
tant anastomotic defects and closing up of rectumwith stapler.61
NICE endorsed techniques for haemorrhoidal artery ligation
(HALO, THD) as an efﬁcacious alternative to conventional haemor-
rhoidectomy or stapled haemorrhoidopexy.62 A recent prospective
randomised trial found that both THD and SH techniques are
equally effective but SH was, however, less effective in preventing
haemorrhoidal recurrence, more expensive and liable to rare, but
severe, post-operative complications.63
7. Pelvic ﬂoor disorders
Stapled transanal rectal resection (STARR) has proved to be an
effective treatment option for patients with obstructed defecation
(OD) syndrome associated with rectocoele and intussusception.64
It has a signiﬁcant early morbidity, which is mostly manageableas an outpatient. Faecal urgency is common but decreases to about
11% at 1 year and continues to fall thereafter.65 The procedure can
be done with either circular or contour-curved staplers. The
contour-curved stapler appears to give more stable clinical results
over time.66 The most common complications were bleeding, small
degree of dehiscence of the suture line, rectal perforation and rec-
tovaginal ﬁstula.67
Laparoscopic ventral mesh rectopexy (LVMRP), previously
described for external rectal prolapsed (ERP), was evaluated for
symptomatic complex rectocoele and was found to be a safe and
effective treatment.68 Increasingly, LVMRP is offered for elderly
patients with full-thickness ERP with mortality, morbidity and
hospital stay comparable with published rates for perineal proce-
dures, with much lower recurrence rate. This might make perineal
procedures for ERP less popular in the future.69
8. Faecal incontinence (FI)
Sacral nerve stimulation (SNS) has been shown to be an effective
treatment for FI and early studies reported success rates of 67–
100%.70 SNS can be effective for up to 10 years, but some patients
experience deterioration in their symptoms over time. The reasons
for this are often not clear.71 Up to 40% of patients have a complete
resolution of their symptoms, whereas 70% could have at least
a 75% reduction in symptoms.72 The incidence of untoward events
associated with sacral nerve stimulation appears to be low. None-
theless, there is a signiﬁcant underreporting of these incidences.73
However, it should be noted that “success” has been arbitrarily
set at a 50% reduction in symptoms, and data are rarely reported
with “intention to treat”.74 Therefore, a recent study raised
concerns about the cost implications of SNS because if cost were
analysed with an intention to achieve continence, SNS may be
signiﬁcantly more expensive than previously reported.74
SNS has been recently used for treatment of selected patients
with chronic constipation,75 chronic anal ﬁssure76 and FI following
anterior resection for rectal cancer.77
There is a growing interest in other promising non-invasive
methods to treat faecal incontinence such as S3 transcutaneous elec-
trical nerve stimulation78 and injection of anal bulking agents.79
9. The way ahead
The next decade will certainly witness increasing interest and
reﬁnement in the techniques of Natural Oriﬁce Translumenal Endo-
scopic Surgery (NOTES) & Sealed Oriﬁce Laparoscopic or Endo-
scopic (SOLE) Surgery in colorectal practice. Earlier reports were
often met with a degree of skepticism, but there is increasing
number of publications demonstrating their feasibility &
safety.80–82 The use of robotics in LCS will establish its role mainly
in the resection of rectal cancer. However, the approach to rectal
cancer surgerymight be completely revolutionised by the introduc-
tion of alternative resection techniques such as totally transrectal
endoscopic total mesorectal excision.83 Without doubt, newer
modalities and approaches will emerge for the management of
pelvic ﬂoor disorders & faecal incontinence.
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